The Unfolded Protein Response (UPR) is an adaptive cellular program used by eukaryotic cells to cope with protein misfolding stress in the Endoplasmic Reticulum (ER). During tumor development, cancer cells are facing intrinsic (oncogene activation) and extrinsic (limiting nutrient or oxygen supply; exposure to chemotherapies) challenges, with which they must cope to survive. Primary brain tumors are relatively rare but deadly and present a significant challenge in the determination of risk factors in the population. These tumors are inherently difficult to cure because of their protected location in the brain. As such surgery, radiation and chemotherapy options carry potentially lasting patient morbidity and incomplete tumor cure. Some of these tumors, such as glioblastoma, were reported to present features of ER stress and to depend on UPR activation to sustain growth, but to date there is no clear general representation of the ER stress status in primary brain tumors. In this review, we describe the key molecular mechanisms controlling the UPR and their implication in cancers.
Introduction
Besides its functions in the regulation of calcium and lipid homeostasis, the endoplasmic reticulum (ER) is the site where elaborated machineries drive protein synthesis and quality control from their nascent forms generated within the ribosomal complexes to their productively folded state which is exported from the ER. This compartment is a complex cellular organelle that must handle approximately one third of all the proteins produced by the cell Dejeans et al., 2015; Hetz et al., 2015) . It is a key compartment that involves an integrated network of molecules including chaperones, foldases and quality control proteins that regulates proteostasis (Balch et al., 2008) . Despite this elaborated machinery, a significant proportion of proteins that transit through the ER is not properly folded and does not fulfill protein quality control standards (Schubert et al., 2000) . These non-properly folded proteins are thus addressed to the ER-associated degradation (ERAD) system, leading them to the cytosol for subsequent ubiquitinylation and degradation by the proteasome . In the case of an acute protein folding demand, the ER folding capacity can be overwhelmed thereby leading to a so-called "ER stress" and to the subsequent activation of an adaptive response, named the Unfolded Protein Response (UPR). The UPR i) transiently inhibits protein translation in order to limit accumulation of newly synthesized misfolded proteins in the ER thereby attenuating the protein misfolding burden; ii) increases the transcription of ER resident chaperones and foldases to increase the folding capacity of the ER; iii) augments the degradative capacity of cells to enhance protein clearance from the ER. If the stress cannot be resolved, the same signaling pathways trigger cell death (Mann and Hendershot, 2006 ).
Tumor development involves many different cellular functions including proliferation, migration, and differentiation that considerably increase protein synthesis and folding demand (Dejeans et al., 2015) . The protein folding demand can also be increased in tumor cells because of intrinsic stresses such as oncogene expression (i.e. MYC; (Hart et al., 2013) ) or aneuploidy (Dejeans et al., 2014) . The ER has therefore to cope with an important protein misfolding burden to allow tumor cells to survive. In addition, tumor microenvironment often varies due to tumor rapid growth and inadequate vascularization.
Therefore, tumor cells are growing in highly selective conditions such as hypoxia, nutrients deprivation and pH change that force them to adapt (Ma and Hendershot, 2004; Mann and Hendershot, 2006) . In response to these stress conditions, tumor cells activate a range of cellular stress-response pathways including the UPR.
Unfolded Protein Response signaling pathways
ER stress is induced by a wide range of cellular perturbations as such nutrients and oxygen privation that allows cells to adapt in these restricted conditions . ER stress leads to engaging the UPR that sets up several mechanisms to reduce protein synthesis, restore proper protein folding and increase the clearance of misfolded proteins from the ER. UPR activation is crucial for cell survival under challenging conditions. However, prolonged UPR activation leads to initiate cell death. In this section, we will first present the molecular actors of the UPR and then describe its involvement in cancers.
The three major mammalian UPR sensors that were discovered about 20 years ago are ATF6α (Activating Transcription Factor 6) (Haze et al., 1999) , IRE1α (Inositol Requiring Enzyme 1) (Tirasophon et al., 1998) , and PERK (PKR-like endoplasmic reticulum kinase) (Harding et al., 1999) . These three sensors activate downstream signaling pathways that lead to reduce the protein misfolding, by temporarily reducing de novo protein synthesis, and increasing protein folding and clearance in the ER (Figure 1) . Importantly, they are controlled by a unique protein chaperone GRP78/BiP. Under basal conditions, GRP78 constitutively binds to the luminal domains of the sensors, preventing their activation Hetz et al., 2015) . When misfolded proteins accumulate in the ER, GRP78
dissociates from the sensors and strongly binds to exposed hydrophobic domains of the misfolded proteins. This leads to prime IRE1α and PERK oligomerization and autophosphorylation (Bertolotti et al., 2000) and to trigger AFT6α export in the Golgi complex . Downstream signaling mediated by these three sensors further controls life or death decisions in cells exposed to either oncogenic or environmental (hypoxia, nutrient deprivation, pH) stresses . a) AFT6 -Upon ER stress, ATF6 (also named ATF6D) is exported from the ER through the secretory pathway. ATF6 has been described to be synthesized as a naturally unstable protein and have a rapid turnover in the ER (Ninagawa et al., 2015) . Under stress conditions, ATF6 is stabilized and can exit the ER through combined dissociation from BiP and action of PDIA5 (Higa et al., 2014) and its activation by proteolytic cleavage occurs in the Golgi apparatus. ATF6α cytosolic domain is released by S1P and S2P-mediated cleavage to a membrane-free form ATF6f that translocates to the nucleus and activates the transcription of genes involved in protein folding and ERAD Dejeans et al., 2015; Yamamoto et al., 2007) . b) IRE1 -IRE1 (also named IRE1α) is an ER resident transmembrane protein with serine/threonine kinase and endoribonuclease (RNase) activities at its cytoplasmic part.
IRE1 dimerizes/oligomerizes in response to ER stress. Its auto-transphosphorylation induces a conformation change leading to activate its endoribonuclease domain . Notably, IRE1 RNase catalyses the non-conventional splicing of XBP1 mRNA together with the RNA ligase RTCB (Jurkin et al., 2014) , shifting the reading frame to translate a stable and active transcription factor XBP1s (Calfon et al., 2002; Lee et al., 2002) . XBP1s activates expression of genes involved protein folding, secretion, ERAD and lipid synthesis (Acosta-Alvear et al., 2007; Chevet et al., 2015; Hetz et al., 2011) . IRE1α
RNase activity is also involved in RNA degradation (so called regulated IRE1-dependent decay -RIDD) including ER-localized mRNA, ribosomal RNA and microRNAs (Han et al., 2009; Hollien and Weissman, 2006; Hollien et al., 2009; Iwawaki et al., 2001; Lerner et al., 2012; Maurel et al., 2014; Upton et al., 2012) . Importantly, the selectivity of IRE1α RNase activity is highly dependent on its oligomerization state but the activation models remain still debated (Bouchecareilh et al., 2011; Ghosh et al., 2014; Han et al., 2009; Tam et al., 2014) . b) PERK -When oligomerizing upon ER stress, PERK trans-autophosphorylates and phosphorylates the translation initiation factor eIF2α that attenuates global protein synthesis Dejeans et al., 2015; Scheuner et al., 2001 ) and the transcription factor NRF2 that controls the antioxidant response . Attenuation of global protein translation not only reduces the folding demand on the ER but also leads to the translational activation of the transcription factor ATF4. This transcription factor induces expression of genes involved in protein folding, amino acid metabolism, autophagy and apoptosis Hetz et al., 2015; Ye and Koumenis, 2009 ). ATF4 induces the transcription of the apoptosis related gene CEBP Homologous Protein CHOP (GADD153) that impacts on the control of cell death/survival outputs upon ER stress .
Moreover, these transcription factors also control the expression of the protein GADD34, which when associated to the phosphatase PP1c is responsible for the dephosphorylation of eIF2α and thus represents a negative feed-back mechanism in the activation of the PERK/eIF2α pathway (Novoa et al., 2001 ).
Endoplasmic reticulum stress and the Unfolded Protein Response in cancers
Over the past decade, ER stress signaling has emerged as a major player in cancer development. The contribution of the UPR to oncogenic processes was first proposed in 2004 (Ma and Hendershot, 2004) and is now well accepted by the community. Elevated expression of UPR actors, including IRE1α, unspliced and spliced XBP1 and ATF6, is observed in a large range of human cancers including brain, breast, gastric, kidney, liver, lung, pancreatic and prostate cancers based on analyses of tissues sections (Table 1) (AlRawashdeh et al., 2010; Andruska et al., 2015; Epple et al., 2013; Fernandez et al., 2000; Fu et al., 2010; Fujimoto et al., 2007; Lee et al., 2006; Lee et al., 2008; Mhaidat et al., 2015; Niu et al., 2015; Pyrko et al., 2007; Scriven et al., 2009; Shuda et al., 2003; Tang et al., 2012; Tsai et al., 2013; Sheng et al., 2015) . In addition, a large number of studies shows that the chaperone GRP78, the key modulator that controls ER stress mechanisms though the activation of the three UPR arms, is overexpressed in many cancers; and contributes to the invasion and metastasis in many human cancers (Dong et al., 2008; Firczuk et al., 2013; Hiss and Gabriels, 2009 ). High tumor grade and reduced survival are often associated with many tumors overexpressing GRP78 (Al-Rawashdeh et al., 2010; Fu et al., 2010; Lee et al., 2008; Niu et al., 2015; Shuda et al., 2003) . In total, UPR activation is crucial for tumor growth but prolonged activation might lead to initiate apoptosis (Dejeans et al., 2015; Ma and Hendershot, 2004) . Furthermore, rapid cell division, hypoxia and anti-cancer drugs generate accumulation of cell stress that leads to UPR activation (Andruska et al., 2015) . Therefore, tight interconnections exist between UPR signaling pathways and major metabolic processes involved in cancer development and progression (Manie et al., 2014) , and examples of these connections will be now presented.
a) Cancer initiation -This is particularly well illustrated in the normal gastrointestinal tract that displays a heterogeneous distribution of UPR components among intestinal cell populations. Indeed, GRP78 expression is lower in intestinal stem cells but is higher in more differentiated transit amplifying cells (Heijmans et al., 2013) . Interestingly, activation of the PERK/eIF2α axis is involved in the loss of stemness in intestinal stem cells (ISC), cells from which most colorectal cancers (CRC) derive (Vermeulen and Snippert, 2014) suggesting that ER stress has a role during cancer initiation in the gastrointestinal tract (Dejeans et al., 2015) . In a colitis-associated cancer model, the IRE1α pathway appears to be an important mediator of ER stress-induced ISC expansion. Indeed, XBP1 loss in epithelial cells results in an increase of cancer initiation due to intestinal stem cell hyper-proliferation (Dejeans et al., 2015) . b) Tumor aggressiveness and dormancy -Cancer cell dormancy is one of the adaptive mechanisms to tumor environment including chemotherapy, nutrient starvation and in vivo microenvironmental challenges. ATF6α is implicated in the regulation of tumor cell dormancy (Schewe and Aguirre-Ghiso, 2008) . Indeed, ATF6α is identified as a survival factor for quiescent but not proliferative squamous carcinoma cells (Schewe and Aguirre-Ghiso, 2008 ). The PERK-eIF2α pathway is also critical for tumor cell dormancy and contributes to anti-cancer drug resistance (Fels and Koumenis, 2006) . In triple negative breast cancers (TNBC), a link between UPR-mediated IRE1α activation and hypoxia-inducible factor HIF-1α contributes to TNBC aggressiveness . Indeed, the IRE1α arm and in particular the splicing of XBP1 mRNA are constitutively activated in TNBC, thereby conferring these tumor cells with higher aggressiveness due to XBP1s-mediated HIF-1α activation . In glioblastoma (GBM), the highest grade of primary brain cancers, tumor invasion is a mark of aggressiveness. Interestingly, the extracellular matrix protein SPARC, involved in tumor invasion, is regulated by IRE1α endoribonuclease activity (Dejeans et al., 2012) . c) UPR-mediated 'secretory switch' in cancer cells -Cancer hallmarks imply the acute secretory reorientation of cancer cells that leads to impact on their cellular functions and their interaction with the tumor microenvironment (Dejeans et al., 2015; Hanahan and Weinberg, 2011) . For instance, change in secreted extracellular matrix (ECM) components and matrix metalloproteases (MMP) affects tumor dissemination and invasion (Bissell and Hines, 2011; Leung and Brugge, 2012) . Modulation of cytokines/chemokines secretion also triggers cancer cell proliferation and tumor angiogenesis (Dejeans et al., 2015) . As an unavoidable organelle for secreted and transmembrane proteins, the ER has a critical impact on this 'secretory switch'. Furthermore the UPR, activated during cancer development, also affects this phenomenon. Epithelial to mesenchymal transition (EMT) enables carcinoma cells to acquire key malignant traits such as migratory and invasion properties, induces stem cell properties and drug resistance (Dejeans et al., 2015) . EMT is fine-tuned by specific transcription factors that repress epithelial markers and up-regulate mesenchymal markers accompanied by morphologic changes. Expression of these transcription factors is often associated with UPR activation. For instance, in breast tumors, increased expression of XBP1s is observed in metastatic tumors, regulated by the EMTinducer SNAIL. TWIST overexpression also correlates with PERK constitutive activation (Feng et al., 2014) . The UPR-induced 'secretory switch' might contribute to this phenomenon. Indeed UPR involvement in EMT was recently shown in breast cancers (Del Vecchio et al., 2014; Feng et al., 2014; Ulianich et al., 2008) . In mammary epithelial cells, overexpression of Serpin B3, a serine/cysteine protease inhibitor, induces chronic UPR that in turn activates NF-κB and leads to IL-6 production, thus resulting in an EMT-like phenotype (Sheshadri et al., 2014) . EMT is also associated with an important change in ECM architecture, allowing tumor cell invasion. Interestingly, inhibition of PERK-eIF2α signaling attenuates cell ability to migrate and to form tumor spheres, thereby indicating that PERK might be involved in EMT-dependent cell malignancy. In GBM, dominant negative form of IRE1α triggers a mesenchymal drift, characterized by modulation of the expression of extracellular matrix, angiogenesis, and inflammatory chemokines (Auf et al., 2010a) . d) Tumor angiogenesis and metabolism -As part of the 'secretory switch', the UPR also affects the expression of pro-angiogenic factors that contribute to tumor angiogenesis.
In an IRE1α-dominant negative GBM model, IRE1α is involved in positive regulation of the secretion of factors such as VEGF-A, IL-1β and IL-6 (Auf et al., 2010a; Drogat et al., 2007) and the cleavage of the mRNA coding for the circadian gene PERIOD1 (Pluquet et al., 2013a) . This pathway represents an important mediator of GBM infiltration that supports to tumor angiogenesis (Auf et al., 2010a) . The PERK-ATF4 branch up-regulates VEGF to induce angiogenesis in response to hypoxic stress (Blais et al., 2006; Chevet et al., 2015; Dejeans et al., 2015; Manie et al., 2014) To activate additional energy supplies, cancer cells have also the capacity to trigger ER stress dependent autophagic pathways. The PERK/eIF2α/ATF4 pathway is activated upon hypoxia in tumor cells and protects these cells from environmental damages through autophagy via LC3B and ATG5 (Bi et al., 2005; Blais et al., 2004; Rouschop et al., 2010) .
Similarly, autophagy is induced by the binding of TRAF2 to IRE1α leading to downstream activation of JNK (Ogata et al., 2006) . In addition, genetic inactivation of XBP1 switches the protein homeostasis (proteostasis) network toward autophagy up-regulation (Hetz et al., 2009 ). These studies illustrate a highly dynamic network that controls cancer cells' ability to adapt and resist to environmental stresses through UPR-dependent mechanisms .
ER stress in primary brain cancers
An analysis of the literature revealed that a significant number of primary brain cancers elicited the features of ER stress either at ultrastructural or molecular levels ( Table 2) . We review these tumor characteristics below. a) Glioblastoma -Glioblastoma multiform (GBM) is the most common primary brain tumor. GBMs represent the highest degree of malignancy of astrocytic lineage neoplasms (WHO Grade IV). Treatment modalities usually include maximal resection, radiotherapy, and chemotherapy with the common use of temozolomide as first-line treatment (Stupp et al., 2005) . However, GBM remain incurable and median survival remains close to 18 months (Pallud et al., 2015) . As most malignant and fast-growing tumors, GBM cells are exposed to high cellular stress levels due to inadequate blood supply, hypoxia, nutrient deprivation, as well as to immune reactions and to various therapeutic treatments. There is strong evidence towards a major involvement of UPR signaling in GBM oncogenesis and resistance to treatments. As such, work from our group has clearly established the contribution of IRE1α signaling in GBM and particularly in tumor growth ( (Auf et al., 2013) , neo-angiogenesis (Auf et al., 2010b; Drogat et al., 2007; Pluquet et al., 2013b) and migration/invasion properties (Dejeans et al., 2012; Jabouille et al., 2015) ). Moreover, the PERK pathway has also been involved in the control of GBM cells metabolism (Hou et al., 2015) and response to treatment Yacoub et al., 2010) . Finally, the ATF6 pathway was recently reported to contribute to GBM resistance to radiotherapy (Dadey et al., 2015) (Figure 2) . b) Lower-grade tumors -Lower-grade astrocytomas (WHO Grade I/II) constitute a heterogeneous group of tumors mostly represented by oligodendrogliomas and astrocytomas, the classification and prognostic indicators of which being completely transformed by molecular diagnosis (Weller et al., 2015) . They usually show a slower evolution than that of GBM, but despite treatments their natural history will ultimately lead to a grade IV tumor. Oligodendrogliomas only show infrequent structural signs of ER involvement (Liberski, 1996) . The expression of chaperone protein GRP78 has been found to be low in oligodendrogliomas and low-grade astrocytomas (Lee et al., 2008) . To our knowledge no other specific signaling pattern of UPR has been assessed in these tumors.
However, these elements should be considered again looking at all ER stress sensors and effectors in the light of recent classification changes. As such we investigated the expression of PERK, IRE1 and ATF6 in normal brain, astrocytes and gliomas (grade II to IV). This unveiled that PERK and IRE1 expression globally increased in glioblastoma and did not vary much in lower grade tumors (Figure 3 (Cimino, 2015) . While the gold standard treatment of grade I meningiomas treatment is surgery, higher grades might benefit from complementary treatments such as radiotherapy (Hasan et al., 2015) . However, no consensual chemotherapy has still been adopted (Moazzam et al., 2013) . Ultrastructural studies showed the presence of closely arranged lamellae of ER in grade I meningiomas, and abundant rough ER in chordoid meningiomas (WHO Grade II) (Couce et al., 2000; Tani and Higashi, 1973) . To our knowledge, no study addressed the specific issue of ER stress in meningiomas. One genetic analysis of different grades of meningioma suggested a role of ATF6 in meningioma aggressiveness (Iglesias Gómez and Mosquera Orgueira, 2014).
Moreover, TXNDC16, an antigen closely associated with the presence of a meningioma, is an ER associated glycoprotein (Harz et al., 2014) . A role of ER stress in meningiomas aggressiveness is indirectly supported by the use of mifepristone in uncontrollable tumors.
This progesterone inhibitor is known to induce ER stress through the activation of ATF6 and PERK leading to eIF2D phosphorylation, even if ATF4 and XBP1s remain unchanged (Dioufa et al., 2010) . However, the clinical results of mifepristone seem mitigated (Cossu et al., 2015; Ji et al., 2015) . Further studies are needed to assess the role of ER stress in anaplastic meningiomas, but the rarity of such lesions limits wide cohort analysis. Usual treatment comprises at least surgical removal, and additional therapeutics according to multimodal risk stratification (Martin et al., 2014) . Four molecular MB subtypes have been described thus far (WNT-, SHH-, groups 3-and 4-MB), showing different clinical courses and response to treatments (Northcott et al., 2011; Northcott et al., 2012) . Several studies highlighted genetic abnormalities linking MB oncogenesis with ER stress and the UPR. One of the main features of WNT-MB is the activation of the WNT/beta-catenin pathway.
CTNNB1 mutations have been shown to lead to high nuclear beta-catenin accumulation, whereas non-mutated cells exhibit low or absent nuclear expression, or cytoplasmic staining of this protein (Eberhart et al., 2000) . In other malignancies such as multiple myeloma, the accumulation of beta-catenin induces ER stress signaling through the phosphorylation of eIF2D and the subsequent expression of CHOP and p21 (Raab et al., 2009) , alternatively in BCR-ABL1 positive CML this occurs through the cytoplasmic accumulation of beta-catenin.
As such one can postulate that beta-catenin induced UPR might be linked to the triggering of EMT, which in turn could be related to MB metastasis (Nasir et al., 2014) . Sonic hedgehog (SHH) -type MBs harbor constitutive activation of the Hedgehog (HH) pathway. Some nonbrain tumors models showed that increased HH signaling activated ER stress sensors and UPR (Marada et al., 2013) . The key role of ER stress in SHH MB is supported by the fact that PERK activation facilitates cerebellar dysplasia and SHH-type MB formation in interferon-gamma activated mouse, this occurring through induction of HH pathways (Lin et al., 2011) . PERK activation also facilitates cell migration and angiogenesis by inducing VEGF secretion (Jamison et al., 2015) . (De Girolami et al., 2008) . To our knowledge, no specific work has yet addressed the relation between pineal tumors and ER stress. Only ultrastructural studies showed signs of ER enlargement in pinealoblastomas, pinealocytomas and papillary tumors (Jouvet et al., 2003; Kline et al., 1979; Tabuchi et al., 1973) . However, special reference should be done about the role of melatonin in ER stress mechanisms. Melatonin is known to be an inducer of antioxidant pathways, and harbors itself ROS scavenger properties. There is evidence of its potential role in ER stressmediated apoptosis and sensitization to ER stress inductors (Fernández et al., 2015) .
Therefore, it could be hypothesized that melatonin can play a role in pineal parenchymal tumors through ER stress, as these tumors conserve a capacity of melatonin secretion (Fevre-Montange et al., 2008) . This however needs further specific studies.
f) Choroid plexus tumor -Choroid plexus (CP) are the anatomical structures secreting the cerebrospinal fluid within the ventricles, formed by a fine maze of fenestrated capillaries. CP tumors are rare entities, representing less than 1% of all primary brain tumors; they are more frequently found in children (Rickert and Paulus, 2001) . Two main histopathological types are encountered: the CP papilloma, a benign neuroectodermal tumor (WHO Grade I), and CP carcinoma (WHO Grade III), which exhibits a worse prognosis.
Surgical treatment is the mainstay of the cure of these tumors, however radiation therapy and chemotherapy may be used in case of surgical remnant, recurrence or leptomeningeal dissemination . Considering the rarity of such lesions, only very few studies focused on ER stress. Ultrastructural studies showed moderate to elevated intracellular enlargement of the ER in CP carcinomas, thus indicating indirectly a potential induction of ER stress (Anguilar et al., 1983; McComb and Burger, 1983) . Another study compared the expression of ER calcium ATPase-type pumps (SERCA enzymes) in normal CP cells, CP papilloma and carcinoma (Ait-Ghezali et al., 2014) . Their expression levels correlate with the activation of ER stress (Højmann Larsen et al., 2001) . Normal CP epithelial cells showed a strong expression of SERCA3, which was decreased in CP papillomas and absent in CP carcinomas. Besides being an interesting biomarker for diagnosis, SERCA dysregulation enlightens ER stress as a potential key feature of CP oncogenesis.
g) Other primary tumors -All other primary brain tumors have been mainly studied on an ultrastructural level, such as hemangioblastomas (Ho, 1987) , myxopapillary ependymomas (Ho, 1990) or subependymal giant cell astrocytomas (Liberski, 1998) . To our knowledge, no signaling analysis in regards to UPR has been made about other intracranial primary tumors.
Conclusions and therapeutic perspectives
From the above observations, it appears that ER-dependent mechanisms, most likely involving proteostasis control pathways play key roles in the pathogenesis and treatment sensitivity of numerous primary brain tumors. In order to better define the functional roles of these pathways in these types of tumors we need to characterize the activation status of ER proteostasis control signaling pathways in larger cohorts of human tumors to be able to propose an ER-based classification. Although these analyses could be performed on paraffin-embeded tumor samples, one might also consider identifying ER stress markers in the cerebrospinal fluid. Although very few studies have described such biomarkers in cases of neurodegenerative diseases, yet their association with primary brain tumors remains to be proven. Moreover, the characterization of UPR signaling in those tumors might provide novel therapeutic strategies either used individually or in combination with existing therapeutics, even if such strategy would require the identification of potent biomarkers to test treatment efficacy. As such, molecules that target IRE1 or PERK catalytic activities (Hetz et al., 2013) could be anticipated to be useful in tumors either dependent on those activities to survive or exhibiting high endogenous activity such as glioblastoma. Moreover, the combination of such targeted therapies with traditional therapeutic protocols such as the Stupp protocol for GBM might reveal efficient to improve therapeutic outcomes for this dismal disease.
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